Literature DB >> 16998653

[Lysis therapy vs. conservative therapy: randomised and prospective study on the treatment of acute central retinal artery occlusion (EAGLE study)].

N Feltgen1, T Reinhard, A Kampik, B Jurklies, H Brückmann, M Schumacher.   

Abstract

In the prospective, randomised and multicenter EAGLE study, the therapeutic efficiency of local intra-arterial fibrinolysis (LIF) versus conservative treatment is being tested in patients with an acute central retinal artery occlusion (CRAO). The most important inclusion criteria are: (1) age between 18-75 years, (2) CRAO not older than 20 h, and (3) visual acuity <0.32. The primary study endpoint is the visual acuity before and 1 month after therapy. The study was started in 2002. To August 2006, 63 of the 200 required patients have been included in the study at 17 medical centers in Germany, Switzerland and Austria.

Entities:  

Mesh:

Year:  2006        PMID: 16998653     DOI: 10.1007/s00347-006-1429-1

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  11 in total

1.  Superselective ophthalmic angiography for diagnostic and therapeutic use.

Authors:  F Y Tsai; D Wadley; J F Angle; K Alfieri; S Byars
Journal:  AJNR Am J Neuroradiol       Date:  1990 Nov-Dec       Impact factor: 3.825

2.  Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion.

Authors:  M Arnold; U Koerner; L Remonda; K Nedeltchev; H P Mattle; G Schroth; M Sturzenegger; J Weber; F Koerner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

3.  Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1 : EAGLE Study report no. 1.

Authors:  N Feltgen; A Neubauer; B Jurklies; C Schmoor; D Schmidt; J Wanke; H Maier-Lenz; M Schumacher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-22       Impact factor: 3.117

Review 4.  [Occlusion of the retinal artery].

Authors:  N Feltgen; D Schmidt; L Hansen
Journal:  Ophthalmologe       Date:  2003-08       Impact factor: 1.059

5.  Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion.

Authors:  N H Atebara; G C Brown; J Cater
Journal:  Ophthalmology       Date:  1995-12       Impact factor: 12.079

6.  Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data.

Authors:  S Beatty; K G Au Eong
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

7.  Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator.

Authors:  G Richard; R C Lerche; V Knospe; H Zeumer
Journal:  Ophthalmology       Date:  1999-04       Impact factor: 12.079

8.  [Minimally invasive therapy for clinically complete central retinal artery occlusion--results and meta-analysis of literature].

Authors:  A S Neubauer; A J Mueller; S Schriever; M Grüterich; M Ulbig; A Kampik
Journal:  Klin Monbl Augenheilkd       Date:  2000-07       Impact factor: 0.700

9.  Intra-arterial fibrinolytic therapy in central retinal artery occlusion.

Authors:  M Schumacher; D Schmidt; A K Wakhloo
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

10.  Selective intra-arterial fibrinolysis of acute central retinal artery occlusion.

Authors:  J Weber; L Remonda; H P Mattle; U Koerner; R W Baumgartner; M Sturzenegger; C Ozdoba; F Koerner; G Schroth
Journal:  Stroke       Date:  1998-10       Impact factor: 7.914

View more
  2 in total

Review 1.  [Surgical treatments for retinal vein occlusion].

Authors:  N Feltgen; H Agostini; L Hansen
Journal:  Ophthalmologe       Date:  2007-04       Impact factor: 1.059

2.  [Comparison of superselective intraarterial fibrinolysis with conservative therapy. Use in patients with acute non-arteritic central retinal artery occlusion].

Authors:  A Wolf; M Schumacher; A S Neubauer; C Schmoor; C Gall; B Jurklies; I Wanke; L Solymosi; H Brückmann; D Schmidt; N Feltgen
Journal:  Ophthalmologe       Date:  2010-09       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.